Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution

Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif., October 31, 2018 Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution... Read more

Thermo Fisher Scientific to Present at the Jefferies 2018 London Healthcare Conference on November 14, 2018

Thermo Fisher Scientific to Present at the Jefferies 2018 London Healthcare Conference on November 14, 2018 WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on... Read more

Merck KGaA, Darmstadt, Germany, Presents First Curious Mind Researcher Award

30 OCT 2018 | DARMSTADT, GERMANY Joint award with manager magazin Barbara Grüner and Sascha Fahl are the first winners Franz-Ulrich Hartl inducted into the Hall of Fame of German Research Darmstadt, Germany, October 30, 2018 – Merck KGaA, Darmstadt, Germany, the vibrant science and technology company, and the German business journal “manager magazine” today presented the... Read more

Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and... Read more

Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement

Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement SANTA CLARA, Calif., October 29, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed... Read more

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products SUNNYVALE, Calif., Oct. 29, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into... Read more

Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.

Site expansion helps high-tech center meet growing demand from global healthcare industry FREDERICK, Md., Oct. 29, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today opened its new business center and biorepository in Frederick, Md. with a ribbon-cutting ceremony. The Frederick campus houses a recently expanded east coast distribution center, new... Read more

Thermo Fisher Scientific to Present at the Baird 2018 Global Industrial Conference on November 7, 2018

Thermo Fisher Scientific to Present at the Baird 2018 Global Industrial Conference on November 7, 2018 WALTHAM, Mass., Oct. 29, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Dan Shine, senior vice president and president, Analytical Instruments, will present at the Baird 2018 Global Industrial Conference on... Read more

Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD

WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 million in cash, subject to post-closing adjustments. The... Read more